SWDCF (Swedencare AB) Other Financing: $-0.0 Mil (TTM As of Mar. 2026)


SWDCF Swedencare AB SWDCF
86 GF Score
Price $3.13
GF Value $5.17
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Swedencare AB Other Financing?

Swedencare AB SWDCF +12.59% 86 Other Financing is $-0.0 Mil as of Mar. 2026. GuruFocus rates SWDCF with a GF Score™ of 86/100 and a GF Value™ of $5.17 (Possible Value Trap). The stock has 6 warning signs investors should review.

Swedencare AB's Other Financing for the three months ended in Mar. 2026 was $0.0 Mil.

Swedencare AB's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.0 Mil.


Swedencare AB Other Financing Historical Data

* Premium members only.

The historical data trend for Swedencare AB's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Swedencare AB Other Financing Chart

Swedencare AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.13 -1.69 -0.00 -0.01 -0.01

Swedencare AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 0.00 0.00 0.00
SWDCF
86GF Score
Swedencare AB SWDCF
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Swedencare AB Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $-0.0 Mil mean?
Swedencare AB (SWDCF) has a Other Financing of $-0.0 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Swedencare AB and its competitors.
Is Swedencare AB's Other Financing too high?
Swedencare AB's current Other Financing is $-0.0 Mil. Overall, Swedencare AB has a GF Score™ of 86/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Swedencare AB's Other Financing compare to KHC and GIS?
Swedencare AB's Other Financing of $-0.0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Consumer Packaged Goods company?
A good Other Financing depends on the Consumer Packaged Goods industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Swedencare AB and its competitors. Swedencare AB's current Other Financing is $-0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Swedencare AB stock overvalued right now?
Based on GuruFocus' analysis, Swedencare AB (SWDCF) is currently considered Possible Value Trap. The stock's GF Value™ is $5.17, compared to a current price of $3.13 — trading 39.5% below its estimated fair value. The current Other Financing is $-0.0 Mil. Swedencare AB's overall GF Score™ is 86/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Swedencare AB (SWDCF), the current Other Financing is $-0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Swedencare AB (SWDCF) Overvalued in 2026?

Based on GuruFocus' analysis, Swedencare AB stock appears to be undervalued. The current stock price of $3.13 is trading 39.5% below its estimated GF Value™ of $5.17. GuruFocus considers Swedencare AB to be Possible Value Trap.

Key valuation signals for SWDCF:

  • Other Financing: $-0.0 Mil
  • GF Value™: $5.17 vs. price of $3.13 (39.5% below fair value)
  • GF Score™: 86/100 with 6 warning signs

No single metric tells the full story. See the SWDCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Swedencare AB Business Description

Address Per Albin Hanssons Vag 41, Medeon Science Park, Malmo, SWE, 205 12
Swedencare AB develops, produces, and sells premium products in the rapidly growing pet healthcare market, focusing on cats, dogs, and horses. Its operations include the development, production, and sale of healthcare products, supported by an extensive portfolio of high-quality brands such as NaturVet, Innovet, PetMD, Rx Vitamins, Nutravet, Rileys, and ProDen PlaqueOff, mainly for pet oral health. The company sources raw materials and manufactures products through its own facilities, subsidiaries, and subcontractors across Sweden, Norway, France, and others, and has expanded its portfolio through acquisitions of various animal health brands and product families. It operates through three segments: North America, which generates the majority of revenue, Europe, and the production segment.
86GF Score

Get the complete analysis for SWDCF

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.13
Price
$5.17
GF Value